NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering the Director's New Innovator Award Program (DP2 Clinical Trial Optional), aimed at supporting early-stage investigators with innovative research projects that have the potential for significant impact in the biomedical sciences. This grant program encourages applications from a diverse range of eligible applicants, including Indian/Native American Tribal Governments, faith-based organizations, and foreign institutions, with no cost-sharing or matching requirements. The total estimated funding for this program is $23 million, with an award ceiling and floor set at $475,000, and approximately 30 awards expected to be made. Interested applicants can reach out to the NIH Director's New Innovator Award Program via email at NewInnovatorAwards@mail.nih.gov, with applications due by August 19, 2026, and project start dates anticipated for September 30, 2026.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government, excluding the NIH Intramural Research Program (NIH IRP);U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).